Stock Price
1.12
Daily Change
-0.13 -10.14%
Monthly
-19.42%
Yearly
-58.52%
Q3 Forecast
1.11

X T L Biopharmaceuticals reported $2.21M in Current Liabilities for its fiscal quarter ending in December of 2024.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
Bioline Rx USD 15.48M 1.45M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025
X T L Biopharmaceuticals USD 2.21M 260K Dec/2024